Danielle Miess told Newsweek she was taken to a back room because she was "freaking out the other patients." ...
A retrospective study of 67 patients found no bleeding after 31 CEUS-assisted drainage procedures, compared with five events ...
A new case report from BMC Infectious Diseases documents the successful treatment of a 75-year-old septic patient with a rare ...
Lutikizumab (ABT-981) met its primary end point and all 8 ranked secondary end points in the phase 3 INTREPID trial ...
AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3 INTREPID study evaluating the safety and efficacy of lutikizumab, an investigational dual-variable-domain interleukin (IL) ...
A little-known system determines what surgeries are worth. It almost always values men more highly.
A previously healthy 14-year-old male has a 3-week history of slowly but progressively worsening dull, aching pain that wakes ...
US pharma major AbbVie yesterday announced positive top-line results from the Phase III INTREPID study evaluating the safety ...
Your toothbrush probably won't make you sick again, but dentists share the situations where swapping it out actually makes sense.
AstraZeneca secured FDA approval for Ultomiris in IgA nephropathy, while Roche, Eli Lilly and others expanded their ...
EXCLUSIVE: Vic Clarke says that her stepson Alfie Zilio, 12, complained of 'excruciating' pain after losing part of his tooth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results